Compared to the effects of the saphenous nerve block and hyaluronic acid intra-articular injection for osteoarthritis of the knee

Compared to the effects of the saphenous nerve block and hyaluronic acid intra-articular injection for osteoarthritis of the knee - Study of the effectiveness of the saphenous nerve block for osteoarthritis of the knee

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024490

Enrollment

Registered

2016-10-20

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

Saphenous nerve block Using 1%mepibacaine 4ml,4 times per week. Under the ultrasound. Hyaluronic acid intra-articular injection Using Purified Sodium Hyaluronate,4 times per week. Under the ultras

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.40 years of age or older 2.Having knee pain 3.Kellgren Lawrence classification grade 1 to 4 4.Neumericl Rating Scale more than 3 5.Agree has been obtained in writing

Exclusion criteria

Exclusion criteria: 1.There is a surgical history of knee 2.With the inside of the knee joint infection 3.There is a local anesthetic allergy 4.Having the following diseases,same side of the Hunter tunnel syndrome, lumbar radiculopathy, shingles-related pain, iliopsoas syndrome,and maignant tumor,active infection diseases,sufficient mental illness that prevents communication 5.Using the following agents,steroids,immunosuppressive agent 6.What principal investigator is determined to unsuitable for safely carrying out the present test

Design outcomes

Primary

Measure	Time frame
Neumerical rating scale(NRS)	—

Secondary

Measure	Time frame
Western Ontario and McMaster Universities osteoarthritis index(WOMAC) Tampa Scale for Kinesiophobia(TSK) Accidental disease	—

Countries

Japan

Contacts

Public ContactMiyuki Niimi

Saku Central Hospital Clinical research and study center

ctroffice@sakuhp.or.jp0267-82-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026